Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.
Amyloid plaques are one of the hallmarks of Alzheimer's disease (AD). This study evaluated a novel microMRI strategy based on "passive staining" of brain samples by gadoteric acid. The protocol was tested at 4.7 T on control animals and APP/PS1 mice modeling AD lesions. T(1) was strongly decreased in passively stained brains. On high-resolution 3D gradient echo images, the contrast between the cortex and subcortical structures was highly improved due to a T2* effect. The brains of APP/PS1 mice revealed plaques as hypo-intense spots. They appeared larger in long compared to short TE images. This suggests that, after passive staining, plaques caused a susceptibility effect. This easily performed protocol is a complementary method to classic histology to detect the 3D location of plaques. It may also be used for the validation of in vivo MRI protocols for plaque detection by facilitating registration with histology via post mortem MRI.
Dhenain
Marc
M
Integrative Imaging Unit, Curie Institute-INSERM, Centre Universitaire. Laboratoire 112, France. Marc.Dhenain@curie.u-psud.fr
Delatour
Benoît
B
Walczak
Christine
C
Volk
Andreas
A
D000544:Alzheimer Disease / Q000175:diagnosis*; D000682:Amyloid / Q000032:analysis*; D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D006571:Heterocyclic Compounds; D008279:Magnetic Resonance Imaging / Q000379:methods*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009942:Organometallic Compounds; D058225:Plaque, Amyloid / Q000473:pathology*; D013194:Staining and Labeling / Q000379:methods*
D000682:Amyloid; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate